Cargando…
Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
Endogenous markers of kidney function are insensitive to early declines in glomerular filtration rate (GFR) and in rodent models, validated, practical alternatives are unavailable. In this study, we determined GFR by modeling the plasma clearance of two compounds, iohexol and inulin, and compared th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430119/ https://www.ncbi.nlm.nih.gov/pubmed/28483858 http://dx.doi.org/10.14814/phy2.13205 |
_version_ | 1783236165560696832 |
---|---|
author | Turner, Mandy E. Laverty, Kimberly J. Jeronimo, Paul S. Kaufmann, Martin Jones, Glenville White, Christine A. Holden, Rachel M. Adams, Michael A. |
author_facet | Turner, Mandy E. Laverty, Kimberly J. Jeronimo, Paul S. Kaufmann, Martin Jones, Glenville White, Christine A. Holden, Rachel M. Adams, Michael A. |
author_sort | Turner, Mandy E. |
collection | PubMed |
description | Endogenous markers of kidney function are insensitive to early declines in glomerular filtration rate (GFR) and in rodent models, validated, practical alternatives are unavailable. In this study, we determined GFR by modeling the plasma clearance of two compounds, iohexol and inulin, and compared the findings to common endogenous markers. All plasma clearance methods of both iohexol and inulin detected a decline in renal function weeks prior to any increase in endogenous marker. Iohexol plasma clearance and inulin plasma clearance had a very high agreement and minimal bias when using 12‐sample models. However, only iohexol could be accurately simplified to a two‐sample, one‐compartment estimation strategy. Following an IV injection of low‐dose iohexol and two timed blood samples at 30 and 90 min, one can accurately approximate a complex 12‐sample strategy of plasma clearance. This method is simple enough to use in routine, longitudinal analysis of larger cohort animal studies. |
format | Online Article Text |
id | pubmed-5430119 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54301192017-05-17 Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD Turner, Mandy E. Laverty, Kimberly J. Jeronimo, Paul S. Kaufmann, Martin Jones, Glenville White, Christine A. Holden, Rachel M. Adams, Michael A. Physiol Rep Original Research Endogenous markers of kidney function are insensitive to early declines in glomerular filtration rate (GFR) and in rodent models, validated, practical alternatives are unavailable. In this study, we determined GFR by modeling the plasma clearance of two compounds, iohexol and inulin, and compared the findings to common endogenous markers. All plasma clearance methods of both iohexol and inulin detected a decline in renal function weeks prior to any increase in endogenous marker. Iohexol plasma clearance and inulin plasma clearance had a very high agreement and minimal bias when using 12‐sample models. However, only iohexol could be accurately simplified to a two‐sample, one‐compartment estimation strategy. Following an IV injection of low‐dose iohexol and two timed blood samples at 30 and 90 min, one can accurately approximate a complex 12‐sample strategy of plasma clearance. This method is simple enough to use in routine, longitudinal analysis of larger cohort animal studies. John Wiley and Sons Inc. 2017-05-08 /pmc/articles/PMC5430119/ /pubmed/28483858 http://dx.doi.org/10.14814/phy2.13205 Text en © 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Turner, Mandy E. Laverty, Kimberly J. Jeronimo, Paul S. Kaufmann, Martin Jones, Glenville White, Christine A. Holden, Rachel M. Adams, Michael A. Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD |
title | Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
|
title_full | Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
|
title_fullStr | Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
|
title_full_unstemmed | Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
|
title_short | Validation of a routine two‐sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD
|
title_sort | validation of a routine two‐sample iohexol plasma clearance assessment of gfr and an evaluation of common endogenous markers in a rat model of ckd |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430119/ https://www.ncbi.nlm.nih.gov/pubmed/28483858 http://dx.doi.org/10.14814/phy2.13205 |
work_keys_str_mv | AT turnermandye validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd AT lavertykimberlyj validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd AT jeronimopauls validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd AT kaufmannmartin validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd AT jonesglenville validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd AT whitechristinea validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd AT holdenrachelm validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd AT adamsmichaela validationofaroutinetwosampleiohexolplasmaclearanceassessmentofgfrandanevaluationofcommonendogenousmarkersinaratmodelofckd |